Mária Rečková
- Molecular Biology
- Surgery top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Co-authors
- David SedmeraRobert G. GourdieRobert P. ThompsonAngela deAlmeidaMichal MegoJozef MardiakDaniela SvětlovskáZuzana Syčová-Milá
- Topics
- Testicular diseases and treatments (20 papers)Neuroblastoma Research and Treatments (13 papers)Sarcoma Diagnosis and Treatment (8 papers)
- Partner nations
- SlovakiaUnited StatesIndia
In The Last Decade
Mária Rečková
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 691
- Surgery 314
- Cardiology and Cardiovascular Medicine 314
- Pulmonary and Respiratory Medicine 213
- Oncology 155
Countries citing papers authored by Mária Rečková
This map shows the geographic impact of Mária Rečková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mária Rečková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mária Rečková more than expected).
Fields of papers citing papers by Mária Rečková
This network shows the impact of papers produced by Mária Rečková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mária Rečková. The network helps show where Mária Rečková may publish in the future.
Co-authorship network of co-authors of Mária Rečková
This figure shows the co-authorship network connecting the top 25 collaborators of Mária Rečková. A scholar is included among the top collaborators of Mária Rečková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mária Rečková. Mária Rečková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 18 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 55 | |
| 9 | 0 | |
| 10 | 10 | |
| 11 | 180 | |
| 12 | 42 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 9 | |
| 16 | Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. | 11 |
| 17 | 25 | |
| 18 | 48 | |
| 19 | 4 | |
| 20 | 98 |
About Mária Rečková
Mária Rečková is a scholar working on Neurology, Surgery and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Testicular diseases and treatments (20 papers), Neuroblastoma Research and Treatments (13 papers) and Sarcoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (314 citations), Molecular Biology (691 citations) and Surgery (314 citations). Mária Rečková has collaborated with scholars based in Slovakia, United States and India. Frequent co-authors include David Sedmera, Robert G. Gourdie, Robert P. Thompson, Angela deAlmeida, Michal Mego, Jozef Mardiak, Daniela Světlovská, Zuzana Syčová-Milá, Jana Obertová and Andy Wessels. Their work appears in journals such as Journal of Clinical Oncology, Circulation Research and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.